Clinical trials recruiting for Soft Tissue Sarcoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of MT-4561 in Patients With Various Advanced Solid Tumors
  NCT06943521 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• Agnostic Therapy in Rare Solid Tumors
  NCT06638931 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
  NCT05000294 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
  NCT04897321 · Phase: Phase 1 · Ages: Up to 21 Years · Sex: All (male and female) · 1 location
• Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
  NCT05539677 · Phase: Not specified · Ages: 1 Year and older · Sex: All (male and female) · 1 location
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
  NCT06333314 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 44 locations
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
  NCT07628634 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
  NCT02811523 · Phase: Phase 1 · Ages: 0 Years to 64 Years · Sex: All (male and female) · 1 location
• Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
  NCT05264974 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
  NCT07261631 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 16 locations
• Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
  NCT06129903 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
  NCT07064018 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Use of GnRHa During Chemotherapy for Fertility Protection
  NCT05328258 · Phase: Phase 3 · Ages: 14 Years to 42 Years · Sex: Female · 17 locations
• tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
  NCT06332274 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Soft Tissue Sarcoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Soft Tissue Sarcoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.